Bioprocess Technology Market Report: Trends, Forecast and Competitive Analysis

Bioprocess Technology Market Report: Trends, Forecast and Competitive Analysis

The future of the global bioprocess technology market looks promising with opportunities in antibiotic, recombinant protein, monoclonal antibody, and biosimilar applications. The global bioprocess technology market is expected to grow with a CAGR of 7%-9% from 2020 to 2025. The major drivers for this market are increasing production of bio-pharmaceuticals, like recombinant protein, vaccines, and rising investments in research and development by biotechnology and pharmaceutical companies.

A total of XX figures / charts and XX tables are provided in this more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global bioprocess technology market report, please download the report brochure.

In this market, recombinant protein is the largest application segment of bioprocess technology. Growth in various segments of the bioprocess technology market are given below:

The study includes trends and forecast for the global bioprocess technology market by product, application, end use, and region as follows:

By Product [Value ($ Million) shipment analysis for 2014 – 2025]:

• Instruments
• Bioprocess Analyzers
• Blood Gas Analyzers
• Osmometers, Cell Counter Systems
• Bioreactors
• Incubators
• Consumables & Accessories
• Culture Media
• Reagents

By Application [Value ($ Million) shipment analysis for 2014 – 2025]:

• Antibiotics
• Recombinant Protein
• Monoclonal Antibodies
• Biosimilars

By End Use [Value ($ Million) shipment analysis for 2014 – 2025]:

• Biopharmaceutical Companies
• Contract Manufacturing Organizations
• Academic Research Institutes
• Food and Feed Industry
• Contract Research Organizations

By Region [Value ($ Million) shipment analysis for 2014 – 2025]:

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Asia Pacific
• China
• India
• Japan
• The Rest of the World
• Brazil

Some of the bioprocess technology companies profiled in this report include Philips Healthcare, Abbott Laboratories, Thermo Fisher Scientific, Alere, B&D, Merck Millipore, Danaher, Lonza, Sartorius Stedim Biotech, and Corning.

Within this market, recombinant protein will remain the largest application segment over the forecast period due to increasing prevalence of chronic and infectious diseases as recombinant therapeutic protein provides important therapies for such diseases.

North America will remain the largest region over the forecast period due to rising prevalence of chronic diseases, developed healthcare infrastructure, and presence of major players in the region.

Features of the Global Bioprocess Technology Market

• Market Size Estimates: Global bioprocess technology market size estimation in terms of value ($M) shipment.
• Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
• Segmentation Analysis: Global bioprocess technology market size by various segments, such as product, application, and end use in terms of value.
• Regional Analysis: Global bioprocess technology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different product, application, end use, and region for the global bioprocess technology market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global bioprocess technology market.
• Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

This report answers following key questions

Q.1 What are some of the most promising potential, high-growth opportunities for the global bioprocess technology market by product (instruments [bioprocess analyzers, blood gas analyzers, osmometers, cell counter systems, bioreactors, and incubators] and consumables & accessories [culture media and reagents]), application (antibiotics, recombinant protein, monoclonal antibodies, and biosimilars), end use (biopharmaceutical companies, contract manufacturing organizations, academic research institutes, food & feed industry, and contract research organizations), and region (North America, Europe, Asia Pacific, and Rest of the World)?

Q.2 Which segments will grow at a faster pace and why?

Q.3 Which region will grow at a faster pace and why?

Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global bioprocess technology market?

Q.5 What are the business risks and threats to the global bioprocess technology market?

Q.6 What are the emerging trends in this bioprocess technology market and the reasons behind them?

Q.7 What are some changing demands of customers in this bioprocess technology market?

Q.8 What are the new developments in this bioprocess technology market? Which companies are leading these developments?

Q.9 Who are the major players in this bioprocess technology market? What strategic initiatives are being implemented by key players for business growth?

Q.10 What are some of the competitive products and processes in this bioprocess technology market, and how big of a threat do they pose for loss of market share via material or product substitution?

Q.11 What M&A activities did take place in the last five years in the global bioprocess technology market?

Report Details

Key Features Description

Base Year for Estimation 2019

Trend Period

(Actual Estimates) 2014-2019

Forecast Period 2020-2025

Pages More than 150

Market Representation / Units Revenue in US $ Million

Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling

Market Segments Product (Instruments (Bioprocess Analyzers, Blood Gas Analyzers, Osmometers, Cell Counter Systems, Bioreactors, and Incubators) and Consumables & Accessories (Culture Media and Reagents)), Application (Antibiotics, Recombinant Protein, Monoclonal Antibodies, and Biosimilars), and End use (Biopharmaceutical Companies, Contract Manufacturing Organizations, Academic Research Institutes, Food & Feed Industry, and Contract Research Organizations)

Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)

Please note: *The report will be completed in 2-4 weeks upon order confirmation*